5 Penny Stocks to Buy in December

Page 5 of 5

1. Arbutus Biopharma Corporation (NASDAQ:ABUS)

Number of Hedge Fund Holders: 13    

Arbutus Biopharma Corporation (NASDAQ:ABUS) markets cures for patients suffering from chronic Hepatitis B virus infection. Reports suggest that the company has identified molecular targets for COVID-19 that will help with the development of treatments for the virus. 

Chardan analyst Keay Nakae recently raised the price target on Arbutus Biopharma Corporation (NASDAQ:ABUS) stock to $5.50 from $5 and kept a Buy rating, noting that a new pipeline drug of the firm was showing strong antiviral activity, terming it an “encouraging start” for the firm. 

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Hudson Bay Capital Management is a leading shareholder in Arbutus Biopharma Corporation (NASDAQ:ABUS) with 1.8 million shares worth more than $7.7 million. 

You can also take a peek at 13 Best Hemp Stocks to Buy Now and Billionaire Dan Loeb’s Top 10 Stock Picks.

Page 5 of 5